Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors

E. Peverelli, E. Giardino, D. Treppiedi, M. Meregalli, M. Belicchi, V. Vaira, S. Corbetta, C. Verdelli, E. Verrua, A. L. Serban, M. Locatelli, G. Carrabba, G. Gaudenzi, E. Malchiodi, L. Cassinelli, A. G. Lania, S. Ferrero, S. Bosari, G. Vitale, Y. TorrenteA. Spada, G. Mantovani

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences